cephalosporin c has been researched along with bay v 3522 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanders, CC; Sanders, WE; Thomson, KS | 1 |
| Amalfitano, G; Fontana, R; Grossato, A | 1 |
| Nord, CE; Norrby, SR; Rylander, M | 2 |
| Kayser, FH; Locher, R; Strässle, A | 1 |
| Fass, RJ | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Eliopoulos, GM; Hodges, TL; Klimm, K; Moellering, RC | 1 |
| Andrews, JM; Ashby, JP; Thornber, D; Wise, R | 1 |
9 other study(ies) available for cephalosporin c and bay v 3522
| Article | Year |
|---|---|
In vitro studies with Bay V 3522, a new oral cephalosporin.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Benzothiazoles; beta-Lactamases; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Microbial Sensitivity Tests; Penicillins | 1991 |
Mechanism of action of BAY v 3522, a new cephalosporin with unusually good activity against enterococci.
Topics: Ampicillin; Benzothiazoles; Cephalosporins; Enterococcus; Microbial Sensitivity Tests | 1991 |
Susceptibility of anaerobic bacteria to BAY v 3522.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Benzothiazoles; Cephalosporins; Microbial Sensitivity Tests | 1991 |
In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.
Topics: Administration, Oral; Bacterial Proteins; Benzothiazoles; Carrier Proteins; Cephalosporins; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1990 |
In vitro activity of BAY v 3522, a new oral cephalosporin.
Topics: Administration, Oral; Amoxicillin; Bacteria; Benzothiazoles; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Pasteurella; Streptococcus pneumoniae; Streptococcus pyogenes | 1990 |
In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benzothiazoles; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Stability; Methicillin; Species Specificity; Staphylococcus aureus; Staphylococcus epidermidis | 1990 |
Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Benzothiazoles; Cephalosporins; Macrolides; Microbial Sensitivity Tests | 1990 |
In vitro activity of BAY v 3522, a new cephalosporin for oral administration.
Topics: Administration, Oral; Bacteria; Benzothiazoles; Cephalosporins; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1990 |
In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
Topics: Bacteria; Bacterial Proteins; Benzothiazoles; beta-Lactamase Inhibitors; Carrier Proteins; Cephalosporins; Hexosyltransferases; Kinetics; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1990 |